Baseline Karnofsky performance status is independently predictive of death within 30 days of intracranial radiation therapy completion for metastatic disease.

30-day mortality Fractionation Metastatic brain disease Palliative Care Performance status Radiation therapy

Journal

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
ISSN: 1507-1367
Titre abrégé: Rep Pract Oncol Radiother
Pays: Poland
ID NLM: 100885761

Informations de publication

Date de publication:
Historique:
received: 27 09 2019
revised: 03 12 2019
accepted: 21 02 2020
entrez: 21 7 2020
pubmed: 21 7 2020
medline: 21 7 2020
Statut: ppublish

Résumé

For patients with brain metastases, palliative radiation therapy (RT) has long been a standard of care for improving quality of life and optimizing intracranial disease control. The duration of time between completion of palliative RT and patient death has rarely been evaluated. A compilation of two prospective institutional databases encompassing April 2015 through December 2018 was used to identify patients who received palliative intracranial radiation therapy. A multivariate logistic regression model characterized patients adjusting for age, sex, admission status (inpatient versus outpatient), Karnofsky Performance Status (KPS), and radiation therapy indication. 136 consecutive patients received intracranial palliative radiation therapy. Patients with baseline KPS <70 (OR = 2.2; 95%CI = 1.6-3.1; Our findings indicate that baseline KPS <70 is independently predictive of death within 30 days of palliative intracranial RT, and that a large majority of patients who died within 30 days received at least 10 fractions. These results indicate that for poor performance status patients requiring palliative intracranial radiation, hypofractionated RT courses should be strongly considered.

Identifiants

pubmed: 32684855
doi: 10.1016/j.rpor.2020.02.014
pii: S1507-1367(20)30028-6
pmc: PMC7352032
doi:

Types de publication

Journal Article

Langues

eng

Pagination

698-700

Informations de copyright

© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

Références

J Clin Oncol. 2006 Mar 10;24(8):1295-304
pubmed: 16525185
Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1633-8
pubmed: 6174490
Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1580-1600
pubmed: 29200112
J Pain Symptom Manage. 2019 Aug;58(2):e5-e6
pubmed: 31029809
Cancer. 1954 Jul;7(4):682-9
pubmed: 13172684
Semin Intervent Radiol. 2007 Dec;24(4):363-74
pubmed: 21326588
Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9
pubmed: 6154024
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
pubmed: 9128946

Auteurs

Shearwood McClelland Iii (S)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Namita Agrawal (N)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

May F Elbanna (MF)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Kevin Shiue (K)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Gregory K Bartlett (GK)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Tim Lautenschlaeger (T)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Richard C Zellars (RC)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Gordon A Watson (GA)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Susannah G Ellsworth (SG)

Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.

Classifications MeSH